Iterum Therapeutics plc (ITRM) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-02-14
5:36 pm
Purchase
2024-12-3113GIterum Therapeutics plc
ITRM
Armistice Capital, LLC1,445,158
4.990%
105,158increase
(+7.85%)
Filing
History
2024-11-14
7:54 pm
Sale
2024-09-3013GIterum Therapeutics plc
ITRM
Point72 Asset Management, L.P.0
0.000%
-850,001decrease
(Position Closed)
Filing
History
2024-11-14
3:31 pm
Purchase
2024-09-3013GIterum Therapeutics plc
ITRM
Armistice Capital, LLC1,340,000
6.030%
1,340,000increase
(New Position)
Filing
History
2024-01-31
4:55 pm
Purchase
2024-01-3013GIterum Therapeutics plc
ITRM
Point72 Asset Management, L.P.850,001
6.300%
850,001increase
(New Position)
Filing
History
2022-01-03
5:30 pm
Sale
2021-12-3113GIterum Therapeutics plc
ITRM
SABBY MANAGEMENT LLC0
0.000%
-516,667decrease
(Position Closed)
Filing
History